LAPTM4B Overexpression is a Novel Independent Prognostic Marker for Metastatic Ovarian Tumors | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Ovarian Cancer

LAPTM4B Overexpression is a Novel Independent Prognostic Marker for Metastatic Ovarian Tumors

Online download statistics by month:

Online download statistics by month: March 2019 to March 2023

	Abstract	Full	Pdf
Mar 2019	14	0	0
Apr 2019	16	0	0
May 2019	33	0	1
Jun 2019	14	0	0
Jul 2019	16	0	1
Aug 2019	22	0	0
Sep 2019	14	0	1
Oct 2019	20	0	0
Nov 2019	16	0	2
Dec 2019	8	0	0
Jan 2020	15	0	0
Feb 2020	34	0	0
Mar 2020	9	0	0
Apr 2020	20	0	0
May 2020	12	0	0
Jun 2020	35	0	1
Jul 2020	24	0	0
Aug 2020	15	0	0
Sep 2020	12	0	0
Oct 2020	16	0	0
Nov 2020	10	0	0
Dec 2020	10	0	0
Jan 2021	12	0	0
Feb 2021	14	0	0
Mar 2021	24	0	0
Apr 2021	20	0	0
May 2021	4	0	0
Oct 2021	12	0	0
Nov 2021	20	0	0
Dec 2021	30	0	0
Jan 2022	20	0	0
Feb 2022	35	0	0
Mar 2022	17	0	0
Apr 2022	18	0	0
May 2022	74	0	0
Jun 2022	32	0	0
Jul 2022	24	0	0
Aug 2022	43	0	0
Sep 2022	45	0	0
Oct 2022	82	0	0
Nov 2022	96	0	1
Dec 2022	25	0	0
Jan 2023	8	0	0
Feb 2023	56	0	0
Mar 2023	22	0	0
Total	1118	0	7